To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Patients with cardiovascular disease undergoing coronary angiography will be recruited and prospectively followed up for the incidence of major adverse cardiovascular events (MACE events), including all-cause mortality, cardiovascular mortality, ischemic stroke, heart failure and rehospitalization. Blood and fecal samples will be collected for further analysis. The basic and clinical information will be collected such as socio-demographic, diet, lifestyle, psychological status and medical history. The biomarkers for the incidence of coronary heart disease and the factors contributing to the poor prognosis of coronary heart disease will be investigated based on multi-omics analysis.
Study Type
OBSERVATIONAL
Enrollment
50,000
Shandong First Medical University
Jinan, Shandong, China
RECRUITINGmajor adverse cardiovascular events
all-cause mortality, cardiovascular mortality, ischemic stroke, heart failure and rehospitalization
Time frame: 2-year outcome and long-term outcome
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.